Tirzepatide x 10 Vials
Tirzepatide is a synthetic peptide studied in metabolic and endocrine research for its activity at both the GIP and GLP-1 receptors. This dual-receptor approach makes it an important research compound for investigating glucose regulation, insulin signalling, appetite pathways, energy metabolism, and gut-brain communication.
This product is supplied as a 10-vial research pack for controlled laboratory and scientific research.
Research Use Only. Not for human consumption, self-administration, diagnosis, treatment, or prevention of disease.
Product Overview
Tirzepatide is a dual GIP/GLP-1 receptor agonist. GIP and GLP-1 are incretin hormones involved in the regulation of metabolism and endocrine function.
By providing a research model involving both receptor systems, scientists can investigate how incretin signalling interacts with pancreatic function, glucose metabolism, appetite regulation, and other metabolic processes.
| Product Detail | Specification |
|---|---|
| Compound | Tirzepatide |
| Product type | Research peptide |
| Pack size | 10 vials |
| Peptide class | GIP/GLP-1 receptor agonist |
| Primary research area | Metabolic & endocrine biology |
| Main pathways | GIP and GLP-1 signalling |
| Intended use | Laboratory research only |
Tirzepatide and Dual Incretin Research
GIP and GLP-1 are naturally occurring hormones involved in post-meal physiological signalling.
GIP is produced primarily by intestinal K cells, while GLP-1 is produced by intestinal L cells and other tissues. Both pathways are involved in communication between the gastrointestinal system, pancreas, brain, and metabolic tissues.
Research into dual receptor activity allows scientists to examine interactions between these two incretin systems.
Areas of investigation include:
- GIP receptor signalling
- GLP-1 receptor signalling
- Insulin-related pathways
- Glucagon regulation
- Glucose homeostasis
- Appetite signalling
- Energy metabolism
- Gastrointestinal physiology
GIP and GLP-1 Receptor Research
The dual mechanism is one of the defining characteristics of this compound.
GIP Receptor Research
GIP signalling is associated with nutrient sensing and pancreatic endocrine function. Researchers investigate the receptor to understand its role in insulin-related responses and broader metabolic regulation.
GLP-1 Receptor Research
GLP-1 signalling is involved in glucose-dependent insulin secretion, appetite-related pathways, gastrointestinal physiology, and communication between metabolic organs.
Studying both pathways together provides researchers with a model for examining coordinated incretin signalling.
Metabolic Research
Metabolic regulation involves multiple interconnected systems controlling glucose, lipids, energy intake, and energy expenditure.
Tirzepatide is therefore relevant to research examining how simultaneous GIP and GLP-1 receptor activity may influence these networks.
Potential research areas include:
- Glucose metabolism
- Insulin signalling
- Pancreatic beta-cell biology
- Glucagon pathways
- Energy balance
- Nutrient sensing
- Metabolic signalling
- Endocrine physiology
Experimental results should always be interpreted according to the research model and study conditions.
Appetite and Satiety Research
Incretin signalling is also connected to the regulation of food intake and satiety.
Researchers investigate interactions between GIP/GLP-1 pathways and neural systems involved in appetite and energy balance. This includes research into communication between peripheral metabolic tissues and the central nervous system.
Research topics may include:
- Satiety signalling
- Food intake
- Appetite-related neural pathways
- Gut-brain communication
- Energy regulation
- Neuroendocrine signalling
These mechanisms involve multiple pathways and should not be reduced to a single biological effect.
Gastrointestinal Research
The gastrointestinal tract plays a major role in incretin biology.
After nutrient intake, intestinal signalling contributes to communication with pancreatic and neural systems. Researchers can study how incretin receptor activation relates to gastric and gastrointestinal processes.
Relevant research areas include:
- Gastric physiology
- Nutrient sensing
- Gastrointestinal signalling
- Post-meal endocrine responses
- Gut-brain communication
Tirzepatide vs GLP-1-Only Compounds
An important research distinction is the number of receptor pathways targeted.
| Feature | Tirzepatide | GLP-1-Only Compounds |
|---|---|---|
| GIP receptor | Yes | No |
| GLP-1 receptor | Yes | Yes |
| Molecular class | Dual incretin analogue | GLP-1 analogue |
| Metabolic research | Yes | Yes |
| Appetite research | Yes | Yes |
| Incretin pathways | Two | Primarily one |
This distinction makes dual-receptor signalling an important area for comparative metabolic research.
Tirzepatide x 10 Vials
This product contains 10 research vials.
The exact quantity per vial should be confirmed from the product label and certificate of analysis because the vial strength was not specified in the product name provided.
| Pack Information | Details |
|---|---|
| Quantity | 10 vials |
| Compound | Tirzepatide |
| Format | Research peptide |
| Strength | Confirm from label/COA |
| Research field | Metabolic & endocrine biology |
| Intended application | Laboratory research |
Researchers should confirm compound identity, vial strength, batch information, purity documentation, and storage requirements before beginning laboratory research.
Research Applications
Incretin Receptor Pharmacology
Investigate interactions with GIP and GLP-1 receptors and their downstream signalling pathways.
Metabolic Biology
Study relationships between incretin signalling, glucose regulation, insulin physiology, and energy balance.
Endocrine Research
Explore communication between intestinal hormones and pancreatic endocrine pathways.
Appetite Research
Investigate hormonal and neural mechanisms associated with satiety and feeding behaviour.
Gastrointestinal Biology
Study the relationship between incretin signalling and gastrointestinal physiology.
Laboratory Quality Considerations
Researchers should review available product documentation before conducting experiments.
Important information may include:
- Compound identity
- Vial strength
- Batch or lot number
- Purity information
- Certificate of analysis
- Packaging integrity
- Storage requirements
Research materials should be handled according to appropriate laboratory safety procedures and manufacturer documentation.
Frequently Asked Questions
What is Tirzepatide?
Tirzepatide is a synthetic peptide analogue studied for its activity at the GIP and GLP-1 receptors and its relevance to metabolic and endocrine research.
What is it researched for?
Research areas include dual incretin signalling, glucose metabolism, insulin pathways, appetite regulation, gastrointestinal physiology, and energy balance.
How many vials are included?
This product contains 10 research vials.
What strength are the vials?
The exact strength should be confirmed using the product label or certificate of analysis.
Is Tirzepatide a GLP-1 compound?
It interacts with the GLP-1 receptor but is not a GLP-1-only compound. It also targets the GIP receptor, making it a dual incretin receptor agonist.
Is this product intended for human use?
No. This product is supplied strictly for laboratory research and is not intended for human consumption or self-administration.
Research-Use Disclaimer
This product is intended exclusively for laboratory and scientific research. It is not a dietary supplement or a product for self-administration.
Do not consume, inject, or administer this material to humans or animals. Researchers are responsible for complying with applicable laws, institutional requirements, laboratory safety procedures, and manufacturer documentation.
For research use only.






